Patient-specific murine I-131-labeled anti-tenascin monoclonal antibody 81C6 radioimmunotherapy for delivering a 44-GY boost to the resection cavity periphery of patients with newly diagnosed primary malignant brain tumors: A feasibility pilot study
Published
Conference Paper
Full Text
Duke Authors
Cited Authors
- Reardon, D; Akabani, G; Friedman, A; Friedman, H; Herndon, J; McLendon, R; Quinn, J; Rich, J; Vredenburga, J; Dejardins, A; Sampson, J; Gururangan, S; Kirkpatrick, J; Wong, T; Dowell, J; Dunn, R; Sathornsumettee, S; Boutlton, S; Coleman, R; Zalutsky, M; Bigner, D
Published Date
- October 1, 2006
Published In
Volume / Issue
- 8 / 4
Start / End Page
- 489 - 489
Published By
Pages
- 1
International Standard Serial Number (ISSN)
- 1522-8517
Conference Name
- 7th Congress of the European-Association-for-Neuro-Oncology (EANO)
Conference Location
- Vienna, AUSTRIA
Conference Start Date
- September 14, 2006
Conference End Date
- September 17, 2006